Clinical Trial Update: An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine [Phase 4]

View source ↗

Summary

An ongoing Phase 4 study is evaluating immunity persistence after a booster dose of a live attenuated varicella vaccine. The trial is sponsored by Sinovac (Dali…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varicella vaccine, live attenuated (varicella vaccine, live attenuated)

Snippet

Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd. | Conditions: Varicella | Phase 4 | Status: ENROLLING_BY_INVITATION